跳至主要内容
临床试验/NCT02020668
NCT02020668Unknown2 期

Phase II Study of Physiotherapy in Rheumatoid Arthritis: Randomized Single Blind Wait-list Controlled Trial

Macmillan Research Group UK1 个研究点 分布在 1 个国家目标入组 82 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
82
试验地点
1
主要终点
Pain

研究概览

简要总结

Despite leading cause of morbidity, treatment strategies for Rheumatic diseases are geared almost exclusively toward medical-pharmacological area away from offering the patient the possibility of an interdisciplinary approach to their disease.

Present study test whether treatment of physiotherapy reduces stiffness and pain inherent in rheumatic disease and improve their quality of life related to health.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 18 years
  • History of Rheumatoid Arthritis (RA) symptoms for less than 7 years
  • Had RA by American College of Rheumatology (ACR) criteria
  • ACR functional RA class I, II or III
  • Hemoglobin more than 8g/dL without evidence of active bleeding
  • Positive for rheumatoid factor (RF) or anti cyclic citrullinated protein
  • standard conventional medicine were allowed within the approved dosage regimen

排除标准

  • connective tissue disease
  • any other alternative or complementary medicine with in last 3 months.
  • corticosteroid, disease modifying medicines
  • Poorly controlled diabetes, hypertension, hepatitis, cardiac disease, liver diseases, carcinoma, drug abuse

结局指标

主要结局

Pain

时间窗: Change from baseline in Numerical Scale Downie at 16 weeks

次要结局

  • Quality of Life(Change from Baseline in Short Form (SF) 36 at 16 weeks)

研究者

发起方
Macmillan Research Group UK
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验